Assistance Publique - Hôpitaux de Paris: COVID-19 trials
The registry lists 112 COVID-19 studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 7 are open to participants now and 0 have results posted.
Phase 2 12Phase 3 16No phase 85(a study in two phases counts in both)
Studies
Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 CohortCompletedNCT04345991Phase 2
- Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 CohortStatus unknownNCT04344782Phase 2
- Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 CohortStatus unknownNCT04344756Phase 2
- Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 PneumoniaStatus unknownNCT04344730Not applicable
- Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the VirusCompletedNCT04344379Phase 3
- Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.Status unknownNCT04343144Phase 2
- Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIROSuspendedNCT04341870Phase 2/3
- Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +CompletedNCT04335019
- Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 PneumoniaCompletedNCT04334850Not applicable
- Protective Role of Inhaled Steroids for Covid-19 InfectionTerminatedNCT04331054Phase 3
- ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 PandemicTerminatedNCT04329195Phase 3
- Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 InfectionTerminatedNCT04325633Phase 3